DQK · Class II · 21 CFR 870.1425

FDA Product Code DQK: Computer, Diagnostic, Programmable

FDA product code DQK covers programmable diagnostic computers used in cardiovascular medicine.

These systems acquire, process, and analyze cardiovascular signals — including ECG, hemodynamic data, and intracardiac electrograms — to support diagnosis and treatment decisions. They are used in cardiac catheterization labs, electrophysiology suites, and intensive care units.

DQK devices are Class II medical devices, regulated under 21 CFR 870.1425 and reviewed by the FDA Cardiovascular panel.

Leading manufacturers include Biosense Webster, Inc., St Jude Medical and Abbott Medical.

436
Total
436
Cleared
142d
Avg days
1976
Since
Growing category - 46 submissions in the last 2 years vs 36 in the prior period
Consistent review times: 129d avg (recent)

FDA 510(k) Cleared Computer, Diagnostic, Programmable Devices (Product Code DQK)

436 devices
1–24 of 436
Cleared Aug 21, 2026
AVVIGO™+ Multi-Modality Guidance System
K253692
Boston Scientific
Cardiovascular · 273d
Cleared Aug 21, 2026
Affera Integrated Mapping System
K262005
Medtronic, Inc.
Cardiovascular · 67d
Cleared Jul 26, 2026
CorVista System® with PCWP Add-On
K253576
Analytics For Life, Inc.
Cardiovascular · 251d
Cleared Jul 15, 2026
EnSite™ X EP System
K262006
Abbott Medical
Cardiovascular · 30d
Cleared Jul 09, 2026
ScioCardio ECG Analysis Platform
K252978
Synergen Technology Labs, LLC
Cardiovascular · 295d
Cleared Jul 02, 2026
ILR ECG Analyzer (IM007)
K253463
Implicity, Inc.
Cardiovascular · 267d
Cleared Jun 12, 2026
OneStim-DUO Cardiac Stimulator (MP5003-4CO)
K253088
Micropace Pty, Ltd.
Cardiovascular · 262d
Cleared Jun 10, 2026
Intra-Operative Positioning System (IOPS) (MC-1)
K261329
Centerline Biomedical
Cardiovascular · 49d
Cleared May 29, 2026
ZEUS Platform (FG0501US)
K252859
iRhythm Technologies, Inc.
Cardiovascular · 262d
Cleared Apr 20, 2026
EnSite™ X EP System
K260212
Abbott Medical
Cardiovascular · 87d
Cleared Apr 13, 2026
ACORYS MAPPING SYSTEM
K253861
Corify Care S.L
Cardiovascular · 131d
Cleared Apr 01, 2026
Synchrony
K253473
Stereotaxis, Inc.
Cardiovascular · 173d
Cleared Feb 24, 2026
HemoSphere Nano Monitor (HSNANO1)
K253186
Edwards Lifesciences, LLC
Cardiovascular · 151d
Cleared Feb 20, 2026
CARTO™ 3 EP Navigation System V8.4
K252972
Biosense Webster, Inc.
Cardiovascular · 156d
Cleared Feb 17, 2026
IOPS Visionary System (MC-3)
K254089
Centerline Biomedical, Inc.
Cardiovascular · 60d
Cleared Feb 09, 2026
Holter ECG and ABP system (HolterABP)
K251591
Edan Instruments, Inc.
Cardiovascular · 262d
Cleared Feb 06, 2026
SafeBeat Rx App
K251218
Safebeat Rx, Inc.
Cardiovascular · 291d
Cleared Jan 28, 2026
NorthStar™ Mapping System
K252164
Imricor Medical Systems
Cardiovascular · 202d
Cleared Jan 18, 2026
CARTO™ 3 EP Navigation System V9.0 with PIU Plus
K254085
Biosense Webster, Inc.
Cardiovascular · 31d
Cleared Dec 19, 2025
STAR Apollo™ Mapping System
K253733
Rhythm AI, Ltd.
Cardiovascular · 25d
Cleared Dec 18, 2025
HemoSphere Alta Advanced Monitoring Platform (ALTAALL1
K252533
Edwards Lifesciences
Cardiovascular · 128d
Cleared Dec 11, 2025
DeepRhythmAI
K253141
Medicalgorithmics S.A.
Cardiovascular · 77d
Cleared Dec 04, 2025
Vektor Computational ECG Mapping System (vMap®)
K252429
Vektor Medical, Inc.
Cardiovascular · 125d
Cleared Oct 24, 2025
CoroFlow Cardiovascular System
K252238
Coroventis Research AB
Cardiovascular · 99d

About Product Code DQK - Regulatory Context

510(k) Submission Activity

436 total 510(k) submissions under product code DQK since 1976, with 436 receiving FDA clearance (average review time: 142 days).

Submission volume has increased in recent years - 46 submissions in the last 24 months compared to 36 in the prior period - suggesting growing market activity in this device classification.

FDA 510(k) Review Time - DQK Product Code

FDA review times for DQK submissions have been consistent, averaging 129 days recently vs 143 days historically.

DQK devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →